NCT03761914 2024-11-19Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersSellas Life Sciences GroupPhase 1/2 Completed26 enrolled 14 charts
NCT03144245 2021-10-12Study of AMV564 in Patients With AMLAmphivena Therapeutics, Inc.Phase 1 Completed53 enrolled